{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:08:52Z","timestamp":1789182532889,"version":"build-2803163510"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1023\/a:1008368905546","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T11:56:00Z","timestamp":1040644560000},"page":"115-116","source":"Crossref","is-referenced-by-count":22,"title":["Combination chemotherapy with irinotecan and adriamycin for refractory and relapsed non-Hodgkin's lymphoma"],"prefix":"10.1016","volume":"11","author":[{"given":"T.","family":"Saotome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008368905546_bb0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1023\/A:1008270717294","article-title":"Topoisomerase-I inhibitors: Review and update","volume":"8","author":"Rolhenberg","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008368905546_bb0010","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1200\/JCO.1990.8.11.1907","article-title":"An early phase II study of CPT-11: A new derivative of camptothecin, for the treatment of leukemia and lymphoma","volume":"8","author":"Ohno","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008368905546_bb0015","first-page":"316","article-title":"A late phase II. trial of a potent topoisomerase I inhibitor, CPT-11, in malignant lymphoma","volume":"11","author":"Tsuda","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008368905546_bb0020","first-page":"113","article-title":"Combination chemotherapy with irinotecan and adriamycin for refractory or relapsed malignant lymphoma A pilot study","volume":"7","author":"Saotome","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008368905546_bb0025","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A Revised European-American Classification of Lymphoid Neoplasms: A proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008368905546_bb0030","series-title":"WHO Offset Publication No. 48","article-title":"Handbook for Reporting Results of Cancer Treatment","year":"1979"},{"key":"10.1023\/A:1008368905546_bb0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/oxfordjournals.jjco.a023263","article-title":"Combination phase I\u2013II study of irinotecan hydrochloride (CPT-11) and carboplatin in relapsed or refractory non-Hodgkin\u2019s lymphoma","volume":"26","author":"Tobinai","year":"1996","journal-title":"Jpn J Clin Oncol"},{"key":"10.1023\/A:1008368905546_bb0040","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ijc.2910500420","article-title":"Effects of CPT-11 in combination with other anti-cancer agents in culture","volume":"50","author":"Kano","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1023\/A:1008368905546_bb0045","first-page":"1556","article-title":"Combination cancer chemotherapy using a DNA topoisomerase inhibitor CPT-11. as a core agent: The in vitro evaluation","volume":"18","author":"Oguro","year":"1991","journal-title":"Jpn J Cancer Chemother"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419550840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419550840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/1\/115\/19477791\/11-1-115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:16:21Z","timestamp":1582182981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419550840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S0923753419550840"],"URL":"https:\/\/doi.org\/10.1023\/a:1008368905546","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}